MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$10,822K
Deemed dividend on
warrants
-$5,673K
Net loss
attributable to controlling...
-$5,149K
Net loss
attributable to...
-$32K
Net loss
-$5,181K
Loss before income
taxes
-$5,171K
Income tax provision
$10K
Loss from operations
-$5,048K
Total other income
(expenses), net
-$123K
Other income
(expense), net
$18K
Total operating
expense
$5,048K
Change in fair value of
other liabilities and...
$93K
Interest
expense-Nonrelated Party
$31K
Interest
expense-Related Party
$10K
Change in fair value of
other liabilities and...
$7K
General and
administrative
$2,687K
Research and development
$2,361K
Back
Back
Income Statement
source: myfinsight.com
Calidi Biotherapeutics, Inc. (CLDI)
Calidi Biotherapeutics, Inc. (CLDI)